Evaluation of Cysteinyl Leukotriene Signaling as a Therapeutic Target for Colorectal Cancer

Colorectal cancer is the third most common cancer worldwide and is associated with significant morbidity and mortality. Current pharmacotherapy options include cytotoxic chemotherapy, anti-VEGF, and anti-EGFR targeting drugs, but these are limited by toxic side effects, limited responses and ultimat...

Descripción completa

Detalles Bibliográficos
Autores principales: Burke, Lorraine, Butler, Clare T., Murphy, Adrian, Moran, Bruce, Gallagher, William M., O'Sullivan, Jacintha, Kennedy, Breandán N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030284/
https://www.ncbi.nlm.nih.gov/pubmed/27709113
http://dx.doi.org/10.3389/fcell.2016.00103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030284/
https://www.ncbi.nlm.nih.gov/pubmed/27709113
http://dx.doi.org/10.3389/fcell.2016.00103

Ejemplares similares